Cargando…

Potentiation of the anti-tumour effects of Photofrin®-based photodynamic therapy by localized treatment with G-CSF

Photofrin(®)-based photodynamic therapy (PDT) has recently been approved for palliative and curative purposes in cancer patients. It has been demonstrated that neutrophils are indispensable for its anti-tumour effectiveness. We decided to evaluate the extent of the anti-tumour effectiveness of PDT c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Golab, J, Wilczynski, G, Zagozdzon, R, Stoklosa, T, Dabrowska, A, Rybczynska, J, Wasik, M, Machaj, E, Oldak, T, Kozar, K, Kaminski, R, Giermasz, A, Czajka, A, Lasek, W, Feleszko, W, Jakobisiak, M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2000
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363378/ https://www.ncbi.nlm.nih.gov/pubmed/10780531 http://dx.doi.org/10.1054/bjoc.1999.1078

Ejemplares similares

Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy
por: Domagala, Antoni, et al.
Publicado: (2018)

Interleukin 12: still a promising candidate for tumor immunotherapy?
por: Lasek, Witold, et al.
Publicado: (2014)

Photodynamic Therapy of Lung Cancer With Bronchial Artery Infusion of Photofrin
por: Okunaka, Tetsuya, et al.
Publicado: (1996)

Response of Photofrin-sensitised mesothelioma xenografts to photodynamic therapy with 514 nm light.
por: Foster, T. H., et al.
Publicado: (1996)

The In Vitro and In Vivo Anticancer Effect of Photomed for Photodynamic Therapy: Comparison with Photofrin and Radachlorin
por: Kim, Jieun, et al.
Publicado: (2023)

Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.
por: Krosl, G., et al.
Publicado: (1995)

Increased efficacy of photodynamic therapy of R3230AC mammary adenocarcinoma by intratumoral injection of Photofrin II.
por: Gibson, S. L., et al.
Publicado: (1990)

Photofrin binds to procaspase-3 and mediates photodynamic treatment-triggered methionine oxidation and inactivation of procaspase-3
por: Hsieh, Y-J, et al.
Publicado: (2012)

Curative effect of the recent photofrin photodynamic adjuvant treatment on young patients with advanced colorectal cancer
por: SUN, BO, et al.
Publicado: (2016)

Cooperative Clinical Trial of Photodynamic Therapy for Early Gastric Cancer With Photofrin Injection(®) and YAG-OPO Laser
por: Mimura, Seishiro, et al.
Publicado: (1998)

Novel After‐loading Interstitial Photodynamic Therapy of Canine Transmissible Sarcoma with Photofrin II and Excimer Dye Laser
por: Hashimoto, Yasuo, et al.
Publicado: (1995)

A Comparison of Singlet Oxygen Explicit Dosimetry (SOED) and Singlet Oxygen Luminescence Dosimetry (SOLD) for Photofrin-Mediated Photodynamic Therapy
por: Kim, Michele M., et al.
Publicado: (2016)

TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy
por: Lee, S Y, et al.
Publicado: (2010)

Statins Impair Antitumor Effects of Rituximab by Inducing Conformational Changes of CD20
por: Winiarska, Magdalena, et al.
Publicado: (2008)

Short- and long-term normal tissue damage with photodynamic therapy in pig trachea: a fluence-response pilot study comparing Photofrin and mTHPC
por: Murrer, L H P, et al.
Publicado: (1999)

Tumour localisation kinetics of photofrin and three synthetic porphyrinoids in an amelanotic melanoma of the hamster.
por: Leunig, M., et al.
Publicado: (1993)

In vitro photosensitization of tumour cell enzymes by photofrin II administered in vivo.
por: Gibson, S. L., et al.
Publicado: (1989)

Irradiance, Photofrin(®) Dose and Initial Tumor Volume are Key Predictors of Response to Interstitial Photodynamic Therapy of Locally Advanced Cancers in Translational Models
por: Oakley, Emily, et al.
Publicado: (2020)

Distribution of Photofrin between tumour cells and tumour associated macrophages.
por: Korbelik, M., et al.
Publicado: (1991)

Photofrin accumulation in malignant and host cell populations of various tumours.
por: Korbelik, M., et al.
Publicado: (1996)

Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II.
por: Grosjean, P., et al.
Publicado: (1998)

Electric Field-Assisted Delivery of Photofrin to Human Breast Carcinoma Cells
por: Wezgowiec, Joanna, et al.
Publicado: (2013)

Photophysical Properties of Protoporphyrin IX, Pyropheophorbide-a, and Photofrin(®) in Different Conditions
por: Myrzakhmetov, Bauyrzhan, et al.
Publicado: (2021)

Oxidation of protein-bound methionine in Photofrin-photodynamic therapy-treated human tumor cells explored by methionine-containing peptide enrichment and quantitative proteomics approach
por: Hsieh, Ya-Ju, et al.
Publicado: (2017)

A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, Photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model.
por: Orenstein, A., et al.
Publicado: (1996)

Cancer stem cells in haematological malignancies
por: Zagozdzon, Radoslaw, et al.
Publicado: (2015)

Photofrin Based Photodynamic Therapy and miR-99a Transfection Inhibited FGFR3 and PI3K/Akt Signaling Mechanisms to Control Growth of Human Glioblastoma In Vitro and In Vivo
por: Chakrabarti, Mrinmay, et al.
Publicado: (2013)

Targeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer Immunity
por: Wachowska, Malgorzata, et al.
Publicado: (2015)

Optimization and regeneration kinetics of lymphatic-specific photodynamic therapy in the mouse dermis
por: Kilarski, Witold W., et al.
Publicado: (2013)

Epigenetic remodeling combined with photodynamic therapy elicits anticancer immune responses
por: Wachowska, Malgorzata, et al.
Publicado: (2014)

Detection of Photofrin Fluorescence From Malignant and Premalignant Lesions in the Bronchus using a Full-color Endoscopic Fluorescence Imaging System
por: Ohsaki, Yoshinobu, et al.
Publicado: (2001)

Short-Term Outcomes of Percutaneous Trephination with a Platelet Rich Plasma Intrameniscal Injection for the Repair of Degenerative Meniscal Lesions. A Prospective, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study
por: Kaminski, Rafal, et al.
Publicado: (2019)

CSF Proteomics of Patients with Hydrocephalus and Subarachnoid Haemorrhage
por: Sokół, Bartosz, et al.
Publicado: (2019)

Comparative Study of Immunomodulatory Agents to Induce Human T Regulatory (Treg) Cells: Preferential Treg-Stimulatory Effect of Prednisolone and Rapamycin
por: Janyst, Michał, et al.
Publicado: (2020)

Aminolevulinic Acid (ALA) as a Prodrug in Photodynamic Therapy of Cancer
por: Wachowska, Małgorzata, et al.
Publicado: (2011)

Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas
por: Separovic, D, et al.
Publicado: (2009)

GRP78-targeting subtilase cytotoxin sensitizes cancer cells to photodynamic therapy
por: Firczuk, M, et al.
Publicado: (2013)

Evaluation of a morpholinothiolporphyrin for use in photodynamic therapy.
por: Woodburn, K. W., et al.
Publicado: (1994)

Very Small Embryonic-Like Stem Cells, Endothelial Progenitor Cells, and Different Monocyte Subsets Are Effectively Mobilized in Acute Lymphoblastic Leukemia Patients after G-CSF Treatment
por: Eljaszewicz, Andrzej, et al.
Publicado: (2018)

Evaluation of radiation doses delivered in different chest CT protocols
por: Gorycki, Tomasz, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hfue161bur5mklggv22us97m2b